Literature DB >> 31100460

Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes.

Neeraj Mangla1, Veeral H Ajmera2, Cyrielle Caussy3, Claude Sirlin4, Sharon Brouha4, Sonia Bajwa-Dulai1, Egburt Madamba1, Ricki Bettencourt1, Lisa Richards1, Rohit Loomba5.   

Abstract

Cardiovascular disease (CVD) is the leading cause of death among patients with nonalcoholic fatty liver disease (NAFLD) and is strongly associated with type 2 diabetes mellitus (DM2).1 Accurately assessing CVD risk in NAFLD patients is critical to improving clinical outcomes.1 Use of liver stiffness measurements to noninvasively assess for liver fibrosis is broadening, and magnetic resonance elastography (MRE) is the most accurate modality in NAFLD.2 However, the association between fibrosis severity on MRE and the degree of CVD risk is unknown. The aim of this study was to determine whether MRE-assessed liver fibrosis stage is associated with CVD risk determined by Framingham risk score (FRS) and coronary artery calcium (CAC).
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID： 31100460      PMCID： PMC6984972          DOI： 10.1016/j.cgh.2019.05.003

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  7 in total

Review 1.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

Review 2.  Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Authors:  Leon A Adams; Quentin M Anstee; Herbert Tilg; Giovanni Targher
Journal:  Gut       Date:  2017-03-17       Impact factor: 23.059

3.  Nonalcoholic Fatty Liver Disease and Incident Cardiac Events: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Irfan Zeb; Dong Li; Matthew J Budoff; Ronit Katz; Donald Lloyd-Jones; Arthur Agatston; Roger S Blumenthal; Michael J Blaha; Ron Blankstein; Jeffrey Carr; Khurram Nasir
Journal:  J Am Coll Cardiol       Date:  2016-04-26       Impact factor: 24.094

4.  Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.

Authors:  Cynthia Hsu; Cyrielle Caussy; Kento Imajo; Jun Chen; Siddharth Singh; Kellee Kaulback; Minh-Da Le; Jonathan Hooker; Xin Tu; Ricki Bettencourt; Meng Yin; Claude B Sirlin; Richard L Ehman; Atsushi Nakajima; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-14       Impact factor: 11.382

5.  The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

6.  Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.

Authors:  Sharon S Brouha; Phirum Nguyen; Ricki Bettencourt; Claude B Sirlin; Rohit Loomba
Journal:  Eur Radiol       Date:  2017-10-20       Impact factor: 5.315

7.  Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA).

Authors:  Matthew J Budoff; Rebekah Young; Gregory Burke; J Jeffrey Carr; Robert C Detrano; Aaron R Folsom; Richard Kronmal; Joao A C Lima; Kiang J Liu; Robyn L McClelland; Erin Michos; Wendy S Post; Steven Shea; Karol E Watson; Nathan D Wong
Journal:  Eur Heart J       Date:  2018-07-01       Impact factor: 35.855
  7 in total
  9 in total

1.  Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease.

Authors:  Jung Gil Park; Jinho Jung; Kritin K Verma; Min Kyu Kang; Egbert Madamba; Scarlett Lopez; Aed Qas Yonan; Amy Liu; Ricki Bettencourt; Claude Sirlin; Rohit Loomba
Journal:  Aliment Pharmacol Ther       Date:  2021-03-25       Impact factor: 8.171

Review 2.  The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk.

Authors:  Cyrielle Caussy; Adrien Aubin; Rohit Loomba
Journal:  Curr Diab Rep       Date:  2021-03-19       Impact factor: 4.810

3.  Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management.

Authors:  Hersh Shroff; Lisa B VanWagner
Journal:  Curr Hepatol Rep       Date:  2020-06-29

Review 4.  Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD.

Authors:  Sílvia Vilarinho; Veeral Ajmera; Melanie Zheng; Rohit Loomba
Journal:  Hepatology       Date:  2021-10       Impact factor: 17.298

5.  Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.

Authors:  Keishi Ichikawa; Toru Miyoshi; Kazuhiro Osawa; Takashi Miki; Hironobu Toda; Kentaro Ejiri; Masatoki Yoshida; Yusuke Nanba; Masashi Yoshida; Kazufumi Nakamura; Hiroshi Morita; Hiroshi Ito
Journal:  Cardiovasc Diabetol       Date:  2021-01-07       Impact factor: 9.951

6.  Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.

Authors:  Lukas W Unger; Bernadette Forstner; Moritz Muckenhuber; Katharina Scheuba; Ernst Eigenbauer; Bernhard Scheiner; Nikolaus Pfisterer; Rafael Paternostro; Michael Trauner; Mattias Mandorfer; Thomas Reiberger
Journal:  Dig Dis Sci       Date:  2019-12-24       Impact factor: 3.199

Review 7.  Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease.

Authors:  Alejandro Campos-Murguía; Astrid Ruiz-Margáin; José A González-Regueiro; Ricardo U Macías-Rodríguez
Journal:  World J Gastroenterol       Date:  2020-10-21       Impact factor: 5.742

Review 8.  Non-alcoholic fatty liver disease and type 2 diabetes: An update.

Authors:  Chi-H Lee; David Tw Lui; Karen Sl Lam
Journal:  J Diabetes Investig       Date:  2022-02-14       Impact factor: 3.681

Review 9.  Multiparametric MR mapping in clinical decision-making for diffuse liver disease.

Authors:  Helena B Thomaides-Brears; Rita Lepe; Rajarshi Banerjee; Carlos Duncker
Journal:  Abdom Radiol (NY)       Date:  2020-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.